It would be hard to disagree with your logic. Yes
Post# of 148169
And yes, I agree the high end of 6-12 seems a bit steep, but I did couch that in the context of the "irrational exuberance" that might accompany the approval of (possibly) the only drug available to reliably save lives.
I also agree with your thoughts regarding the use of any profits (little as they may be) associated with a COVID approval -- although I would add that it might be possible to leverage those funds to also help to uplist to NASDAQ -- which isn't an obsession for me -- but is something I'd like to see happen so we can put these morons (MM, Short Attacks, etc) behind us.